Intralink Spine
1501 Bull Lea Road
Suite 103
Lexington
Kentucky
40511
United States
Tel: 502-419-8099
Website: http://www.intralinkspine.com/
Email: LHawkins@IntralinkSpine.com
About Intralink Spine
Formed to manufacture and exclusively sell the Réjuve injectable medical device to treat Degenerative Disc Disease (DDD), low back pain, and related spinal diseases such as scoliosis. A significant opportunity exists to better serve both surgical and non-surgical patients by offering an injectable solution that directly strengthens disc tissues, improves disc nutritional flow, reduces neural compression caused by disc bulge, and corrects the cause of theinstability associated with spinal disc diseases without the cost and risk of surgery.
YEAR FOUNDED:
2004
LEADERSHIP:
Founder: Stephen Hochschuler
CEO: Lyle Hawkins
CSO: Tom Hedman
PRODUCTS:
Rejuve
11 articles about Intralink Spine
-
Intralink-Spine Expanding Clinical Data in Australia
11/16/2020
Intralink-Spine, Inc. announces that clinical sites in Australia are once again adding data supporting the safety and efficacy of their novel, injectable, nano-tethering device for the treatment of spinal disc degeneration and chronic low back pain.
-
Intralink-Spine, Inc. Adds Clinical Sites in Australia
7/14/2020
Intralink-Spine, Inc. (ILS) announces the expansion of clinical trials for their patented injectable medical device, Réjuve ®, intended in Australia for the treatment of low back pain. “We’re pleased that Dr. Yu and Dr. Green have joined Dr. Rosenberg to participate in the GEM-SE clinical study for low back pain,” says Lyle Hawkins, CEO of Intralink-Spine, Inc. “Low back pain due to degenerative disc disease is v
-
Intralink-Spine, Inc: Announces Continuation of CLBP Clinical Study
1/7/2020
ILS will be adding new sites to broaden Principal Investigator (PI) and participant representation in Australia.
-
Intralink-Spine, Inc. Announces ISO-13485 Certification
10/8/2019
ISO 13485:2016 is an internationally recognized quality standard specific to the medical device industry and signifies Intralink-Spine’s commitment to the highest level of medical device quality controls and meeting customer and international regulatory expectations.
-
Intralink-Spine, Inc. Expands Clinical Studies in Australia
8/20/2019
Expansion of clinical trials in Australia for their patented medical device for the treatment of low back pain, called Réjuve
-
Intralink-Spine, Inc. Goes Down Under To Extend Clinical Studies
3/5/2019
Intralink-Spine, Inc. announces the initiation of clinical trials in Australia for their patented medical device for the treatment of low back pain, called Réjuve™. “We’re excited that patient enrollment has begun in Australia.
-
Exciting New Data For Intralink Spine’s Réjuve Treatment For Low Back Pain
5/16/2017
-
Intralink Spine’s Réjuve Treatment Nears Completion Of Safety Study And Begins Multi-Site Pivotal Study
1/31/2017
-
Intralink Spine’s Réjuve Treatment Eliminates Low Back Pain
10/27/2016
-
Intralink Spine Continues To See Positive Clinical Results For The Treatment Of Low Back Pain
8/30/2016
-
Intralink Spine, Excited About Early Patient Feedback Regarding Its Treatment For Low Back Pain
8/9/2016